Citadel Securities Maintains an 'Edge Negative' on Celgene (CELG); Behind the Smoke and Mirrors: Revlimid Ex-U.S. Growth Updated Guidance Suggests Slowdown Ahead
Go back to Citadel Securities Maintains an 'Edge Negative' on Celgene (CELG); Behind the Smoke and Mirrors: Revlimid Ex-U.S. Growth Updated Guidance Suggests Slowdown Ahead| Celgene Corp. (NASDAQ: CELG) | Delayed: 108.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.24 | 52 Week High | $127.00 | |||
| Open | $7.85 | 52 Week Low | $93.05 | |||
| Day High | $108.24 | P/E | 32.12 | |||
| Day Low | $108.24 | EPS | $3.37 | |||
| Volume | 0 | |||||
